NCT00004482: Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis |
|
|
| Completed | 2 | 40 | US | Cyclosporine, methylprednisolone, Muromonab-CD3, prednisone | Mayo Clinic | Myocarditis, Giant Cell Myocarditis | 07/05 | 07/06 | | |
